Healthequity Inc (HQY) Insider Stephen Neeleman Sells 40000 Shares

Also, insider Stephen Neeleman sold 40,169 shares of Healthequity stock in a transaction dated Thursday, March 16th. Zooming out to the 200-day moving average, shares have been seen trading -47.86% away from that value. Avondale maintained it with "Market Outperform" rating and $27 target in Wednesday, March 23 report. Insiders have sold a total of 320,950 shares of company stock worth $14,606,086 in the last 90 days.

On Friday, March 17th, Stephen Neeleman sold 53,218 shares of Healthequity stock. The stock was sold at an average price of $46.19, for a total transaction of $2,564,376.42. Finally, Cantor Fitzgerald initiated coverage on Healthequity in a report on Thursday, March 30th. The stock was sold at an average price of $45.96, for a total value of $1,846,167.24. The company has market cap of $3.03 billion. Shares are trading at $52.68 just a bit higher than the 50 day moving average which is $45.46 and barely above the 200 day moving average of $43.95. Healthequity Inc has a one year low of $26.92 and a one year high of $49.69. The stock of Healthequity Inc (NASDAQ:HQY) earned "Buy" rating by Chardan Capital Markets on Tuesday, December 13. The company reported $0.07 EPS for the quarter, beating analysts' consensus estimates of $0.05 by $0.02. The firm had revenue of $46.83 million during the quarter, compared to analyst estimates of $45.55 million. The business's quarterly revenue was up 25.9% compared to the same quarter previous year.

HealthEquity, Inc., launched on October 18, 2002, is a provider of a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. If you are viewing this piece of content on another website, it was stolen and republished in violation of US and worldwide trademark and copyright law. Following the completion of the sale, the executive vice president now directly owns 5,132 shares in the company, valued at $223,755.20. BlackRock Inc. increased its stake in Healthequity by 157,852.9% in the first quarter.

Stock has got outperform rating from 3 analyst of Thomson Reuters whereas 1 analyst given hold rating to the stock. Elkfork Partners LLC raised its position in shares of Healthequity by 0.4% in the first quarter. Berkley W R Corp sold 2.21M shares as the company's stock rose 4.44% with the market. State of Alaska Department of Revenue raised its position in shares of Healthequity by 4.3% in the first quarter. They set an "outperform" rating for the company. Finally, Allegis Investment Advisors LLC raised its position in shares of Healthequity by 2.4% in the first quarter. Peregrine Capital Management LLC now owns 743,830 shares of the company's stock worth $29,776,000 after buying an additional 44,792 shares in the last quarter.

A number of brokerages have recently issued reports on HQY. The firm now has a "buy" rating on the stock. The company was maintained on Wednesday, March 23 by Barrington Research.

September 12 investment analysts at Raymond James kept the stock rating at "Outperform" and moved up the price target from $24.00 to $40.00. They set an "overweight" rating and a $50.00 price objective on the stock.

TRADEMARK VIOLATION WARNING: "Insider Selling: Healthequity Inc (HQY) Insider Sells $1,934,400.00 in Stock" was originally published by Sports Perspectives and is owned by of Sports Perspectives. Wells Fargo & Co started coverage on Healthequity in a report on Tuesday, March 14th. The firm has "Buy" rating given on Tuesday, December 13 by Chardan Capital Markets. The company now has a consensus rating of "Buy" and a consensus price target of $45.55. Its platform provides an ecosystem where consumers can access their tax-advantaged healthcare savings, compare treatment options and pricing, evaluate and pay healthcare bills, receive personalized benefit and clinical information, earn wellness incentives and make educated investment choices to grow their tax-advantaged healthcare savings.

  • Zachary Reyes